Werewolf Therapeutics (HOWL) Change in Cash (2020 - 2026)

Werewolf Therapeutics has reported Change in Cash for 7 years, with the latest figure at -$25.4 million in Q2 2026.

• Change in Cash for Q2 2026 came in at -$25.4 million, down 71.68% year-over-year; the trailing twelve-month figure through Jun 2026 was -$56.5 million (up 2.62% YoY), and the FY2025 annual result was -$54.3 million, down 25.14% from the prior year.
• Change in Cash eased to -$25.4 million in Q2 2026, from -$10.6 million in the prior quarter.
• Over five years, Change in Cash peaked at $38.6 million in Q1 2023 and troughed at -$25.4 million in Q2 2026.
• A 5-year average of -$7.6 million and a median of -$10.9 million in 2022 frame the typical range for Change in Cash.
• The largest YoY upside for Change in Cash was 378.99% in 2023 against a maximum downside of 620.29% in 2023.
• A 5-year view of Change in Cash shows it stood at -$11.1 million in 2022, then soared by 138.54% to $4.3 million in 2023, then slumped by 375.71% to -$11.8 million in 2024, then gained by 26.8% to -$8.7 million in 2025, then sank by 192.99% to -$25.4 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were -$25.4 million in Q2 2026, -$10.6 million in Q1 2026, and -$8.7 million in Q4 2025.